The plasma aldosterone to renin activity ratio (A/PRA) ratios in patients with primary aldosteronism were associated with unsuppressed plasma renin activity (PRA). was assessed retrospectively in 103 patients with primary aldosteronism including 74 patients with surgiAlthough the mean values of the A/PRA ratio differed significantly between the groups, complete separation cally proven adrenal cortical adenoma (APA) and 29 patients with idiopathic adrenal cortical hyperplasia was not obtained. The serum potassium level at time of testing did not influence the diagnostic value of the (IHA). The results were compared with those obtained in 31 patients with essential hypertension (EH) and 45 A/PRA ratio, although an inverse correlation between serum potassium and the A/PRA ratio was found in the healthy normotensive controls. The upper limit of normal A/PRA ratio, as obtained in the controls was 17.8. patients with APA. This study supports the high sensitivity of the A/PRA ratio in diagnosis of primary aldosThis value was exceeded in 89% of patients with APA; postoperatively it decreased in 97% of the APA group, teronism, however, a single determination with a normal result may not be sufficient for exclusion of the disease. and returned to normal in 81%. In the IHA group the A/PRA was elevated in 70% of patients. The normal
Introduction
suspected primary aldosteronism. Primary aldosteronism has been hitherto considered However, reports from several centres have dema rare cause of hypertension. Its occurrence has been onstrated a limited effectiveness of this test, since generally estimated at less than 2% of the total in a sizeable proportion of patients the plasma pothypertensive population. Hypertension and bioassium may be normal. 2, 3 In 1981 Hiramatsu et al 4 chemical abnormalities result from excessive proposed a simple test, practicable in an outpatient secretion of aldosterone from the adrenal cortex setting, using a calculated ratio of plasma aldowhich is due to the presence of an adenoma, or to sterone concentration to plasma renin activity idiopathic or primary adrenal cortical hyperplasia.
(A/PRA). Subsequently, several authors reported Familial forms of primary aldosteronism, aldos-A/PRA ratio in patients with primary aldosteronism teronism caused by adrenal carcinoma, or extraand demonstrated its usefulness for screening puradrenal ectopic aldosterone hypersecretion are rare. 1 poses. [4] [5] [6] [7] Establishing the aetiology of primary aldosteronism
In the present study, to further support the diagis important for therapeutic decisions; cortical adennostic value of the A/PRA ratio, we analyse retroomas are best treated surgically, while conservative spectively a large group of patients with primary treatment is usually advocated for non-tumorous aldosteronism treated in our institution between forms.
1974 and 1992. The retrospectively assessed A/PRA Recurrent hypokalaemia in a hypertensive patient ratios of patients with tumorous and non-tumorous is the typical feature pointing to a possible diagnosis primary aldosteronism are compared to those of of primary aldosteronism. The demonstration of a patients with essential hypertension and of healthy lowered plasma potassium concentration in the face normotensive controls. of an increased urinary potassium excretion has long been considered the basic screening test, indi-proven adrenal cortical adenomas, 29 patients (11 plasma aldosterone concentration was normal in all cases. Secondary forms of hypertension had been men and 18 women) aged 17-60 years (mean age 45.2 ± 1.6 years) with primary aldosteronism withexcluded involving the same procedures as in patients with primary aldosteronism. None of the out discernible adrenal tumours, classified as adrenal cortical hyperplasia, and 31 patients (12 men patients had diabetes, elevated serum creatinine or overt hepatic dysfunction. and 19 women) aged 19-74 years (mean age 40.2 ± 2.4 years) with essential hypertension.
The control group included clinically healthy normotensive volunteers recruited similarly to the EH The control group consisted of 45 healthy normotensive volunteers (23 men and 22 women) aged 25-group. All tests were done during hospitalisation, after 50 years (mean age 35.9 ± 1.1 years).
As a rule, patients with primary aldosteronism diuretics including spironolactone had been withheld for at least 4 weeks, and any other drugs posswere referred to our institution because of recurrent hypokalaemia and hypertension diagnosed elseibly interfering with plasma aldosterone and renin activity, for at least 2 weeks. None of the patients where. The only exceptions concerned three patients referred with normal plasma potassium had been previously receiving angiotensin-converting enzyme (ACE) inhibitors. In a few cases concentration but with suggestive clinical features (each patient exhibiting at least three of the followwhere hypotensive therapy was necessary, calcium channel blockers were given, but omitted on the day ing: muscular weakness, polyuria with nocturia, polydipsia, parestesia) and one normokalaemic of the study. The subjects had not been subject to sodium restriction during the preceding months or patient with a previously demonstrated adrenal tumour. Other causes of secondary hypertension at the time of the study and remained on normal sodium intake as evidenced by 24-h urinary sodium had been excluded on the basis of clinical findings and an array of laboratory tests, including urinary excretion of 120-160 mmol. Most patients with primary aldosteronism received potassium salts p.o. free corticoids, urinary catecholamines and metabolites, renal ultrasonography, and in some cases, and had high urinary potassium excretion. In the remaining groups potassium intake was normal aortonephrography. The diagnosis of primary aldosteronism was based on increased plasma aldo-(urinary excretion 20-40 mmol/24 h). After overnight fasting and 30 min rest lying sterone concentration and/or increased urinary aldosterone excretion in the face of low PRA unredown, blood samples were taken without stasis from an antecubital vein, placed in the test tubes containsponsive to stimulation by furosemide and 4-h upright posture. However, in three hypokalaemic ing sodium EDTA and immediately centrifuged at 4°C for 10 min, whereupon plasma was separated, patients with eventually visualised adrenal tumours, the requisite of suppressed PRA was omitfrozen and stored at −20°C until analyses were performed within 2 weeks of freezing. Blood for serum ted.
The visualisation techniques used, depending on potassium concentration was collected in separate test tubes and analysed within a few hours. In 63 of the progress of their availability, included adrenal phlebography with adrenal venous sampling, scinthe patients with primary aldosteronism, identical studies were repeated 2-12 weeks postoperatively. tigraphy, ultrasonography, computerised tomography, and magnetic resonance of the adrenals. DemPlasma aldosterone concentration was determined by radioimmunoassay (RIA), according to the onstration of an adrenal tumour or a unilateral aldosterone hypersecretion usually by more than method of Ignatowska-Ś witalska 8 with a modification which omitted thin layer chromatography of one of these techniques provided the diagnosis of an aldosterone-producing tumour in all the 74 patients the dichloromethane extract. Initially we used the anti-aldosterone antibodies (088) obtained from NIH brought to surgery. This subsequently provided histological confirmation of the diagnosis of an aden-(Bethesda, MD, USA), replaced later by the Calbiochem antibodies. Two millilitres of plasma were oma of the adrenal cortex (APA).
In the 29 patients with primary hyperaldosteronused for dichloromethane extraction. Recovery for the extraction procedure was 90 ± 8% (n = 40). The ism in whom at least two techniques had failed to demonstrate an adrenal tumour, the diagnosis of extract was evaporated and dissolved in RIA buffer (0.1 M borate, pH = 8.0, bovine albumin 0.5%). We idiopathic adrenal cortical hyperplasia (IHA) was assumed with the ensuing indication for conservaused the standard in the range 20.8-693.5 fmol (7.5-250 pg) per test tube. Working dilutions of the antitive treatment.
Usually the case histories included the results of body were adjusted to obtain zero binding at 30-50%. The standard or samples in presence of the more than one determination of PRA and plasma aldosterone concentration; for the purpose of this antibody were incubated overnight at 4°C with 10 000 cpm of 3 H-aldosterone (Amersham TRK 196) study we selected those which were synchronous, preferably with a corresponding serum potassium as the labelled tracer antigen. Bound antibody was separated from free antigen with charcoal/dextran determination, and conformed to the basal conditions at the time of sample collection. As a rule, suspension and 10 min incubation. After centrifugation at 4°C, the supernatant was decanted into scinthese were not the same determinations as those serving for the initial diagnosis of primary aldostillation cocktail and radioactivity of the antibodybound fraction was measured in the Packard beta teronism.
The essential hypertension (EH) group consisted scintillation counter. Aldosterone concentration was interpolated from the standard curve. Crossof patients with mild to moderate hypertension recruited for various previous clinical studies. Basal reactivity with cortisol, corticosterone and deoxy-corticosterone of both these antibodies was less than had unsuppressed PRA at the initial selection, two had an elevated A/PRA ratio (97 and 261 0.001%, with intra-and inter-assay coefficient of variation of 8%, for a mean value of 263 mol/l respectively); and the third patient had a normal ratio (8.2), but the removal of his adrenal adenoma (9.5 ng%) and 15%, for a mean value of 336 pmol/l (12.1 ng%), respectively. The normal values of was followed by normalisation of plasma and urinary aldosterone, disappearance of hypokalaemia, plasma aldosterone for our laboratory, as determined by this method, with either of the antibodies polydipsia, polyuria and muscular weakness, and improved control of his residual hypertension. used ranged between 83 pmol/l (3 ng%) and 416 pmol/l (15 ng%).
The A/PRA ratio of patients with adrenal cortical hyperplasia ranged from 3.9 to 736, median 31.2, PRA was determined using Renk kit (Cea Ire Sorin, Italy), replaced later with the RJ 131 kit with the mean value of 74.9 ± 25.3. In this group nine (30%) patients displayed normal ratios; in (Immunotech, Czechoslovakia). Angiotensin I was generated in vitro within 1 h (or 2 h for lower these nine cases the basal PRA ranged from 0.04 to 0.7 pmol/l/s (0.2-3.4 ng/ml/h, mean 1.6 ± 0.3 expected PRA) of enzymatic reaction at 37°C and pH 6.0. For valid assay the concentration of free circulng/ml/h)). The EH group displayed A/PRA ratios ranging ating angiotensin (blank) was not higher than 0.02 pmol/l/s (0.1 ng/ml/h). Intra-and inter-assay varibetween 0.5 and 37.5, median 7.0 (mean 11.8 ± 2.0). In 22.6% of patients in this group the ratios were ation coefficient with both these methods was 6% and 8% for a mean value of 0.4 pmol/l/s elevated.
The differences between the mean values of the (1.6 ng/ml/h), respectively, and the normal basal PRA for our laboratory ranged between 0.1 and 0.9 A/PRA ratio of the APA group and those of the remaining groups were highly statistically signifipmol/l/s (0.5 and 4.2 ng/ml/h) with either of the kits.
cant (P Ͻ 0.05). Likewise, the IHA group differed significantly from the EH group and the control The A/PRA ratio was calculated from plasma aldosterone concentration in ng% and PRA in group.
The assessment of the relationships of the A/PRA ng/ml/h, and was expressed as an absolute number.
Serum potassium concentration was estimated by ratio to plasma aldosterone concentration and PRA by the Spearman's rank test demonstrated that in flame photometry (normal range 3.5-5.0 mmol/l).
Statistical analysis of the results was done using both the APA and IHA groups the A/PRA correlated with plasma A (r = 0.540, P Ͻ 0.001 for APA, and r the PC-Super-Stat system. The results were expressed as ranges; medians and arithmetic means = 0.372, P Ͻ 0.05 for IHA), but stronger significant negative correlations were disclosed between with standard errors, depending on the distribution of the parameters. After an initial appraisal of the A/PRA and PRA (r = −0.837 for APA and r = −0.887 for IHA, P Ͻ 0.0001 in both groups). distribution of results, the unpaired and paired group differences of the A/PRA ratios were comThe changes in the A/PRA ratios following surgical removal of adrenal adenoma are presented in pared using the Wilcoxon test. For sets of parameters characterised by normal distribution and Figure 2 . Postoperatively, the A/PRA ratio decreased in 61 (97%) out of 63 analysed cases of APA, and equal variance, Student's t-test for unpaired samples was applied. The interrelations between parameters in 51 (81%) it attained a normal value. Thus in two patients the elevated A/PRA ratio did not fall postwere calculated using the Spearman rank test. A Plevel of less than 0.05 was regarded as statistically operatively. In one of them a second aldosteroneproducing adenoma in the contralateral adrenal has significant. been subsequently demonstrated. In the second case a repeated postoperative testing disclosed a normal Results ratio. The mean group A/PRA value decreased significantly from 221.1 ± 37.7 preoperatively to 14.9 ± The results of synchronous plasma aldosterone, PRA and serum potassium measurements as well as the 2.8 postoperatively (P Ͻ 0.01). Serum K concentration synchronous with A/PRA calculated A/PRA ratios are presented in Table 1 . The individual A/PRA ratios in the four investigated ratio was available in 80 patients with primary aldosteronism, including 58 with APA and 22 with IHA. groups are depicted in Figure 1 .
In healthy normotensive controls, the A/PRA ratio In the APA group 27 patients (46%) had normal serum K (у3.5 mmol/l). Out of these, 23 (85%) had ranged between 1 and 25, median 4.8, with the mean value of 6.4 ± 0.8 (s.d. = 5.7). The upper limit of an elevated A/PRA ratio. In the IHA group, normal serum K was found in 16 (73%) patients, including normal was set at 2 standard deviations above the mean, which corresponded to 17.8. The A/PRA ratio 10 (62.5%) with elevated A/PRA ratio. A statistically signicant inverse correlation exceeded this limit in three subjects (6.6%) of the control group.
between the A/PRA value and serum K concentration was found in the APA group (r = −307, P Ͻ In patients with adrenal cortical adenoma, the A/PRA ratio ranged from 6.6 to 1710, median 125.1, 0.05), but not so in the IHA group (r = −0.177, P Ͼ 0.5). with the mean value of 223.8 ± 34.2. In eight (11%) patients of this group the ratios were within the norIn 51 patients (26 with APA and 25 with IHA), the records permitted repeated calculations of A/PRA mal limits; these patients were characterised by normal basal PRA ranging from 0.2 to 0.9 pmol/l/s (0.9-ratio in basal condition. The comparison of the double sets of results ( Figure 3 ) did not disclose signifi-4.2 ng/ml/h), mean 0.5 ± 0.3 pmol/l/s (2.4 ± 1.2 ng/ml/h). Out of three patients with APA who had cant difference of the mean values (P Ͼ 0.5). The 376 2.7 ± 0.06 2.9 ± 0.08 4 ± 0.06 4 ± 0.08 Figure 2 The A/PRA ratio before and after surgical removal of adenoma in 63 patients with APA (mean ± s.e.). The results of our retrospective study indicate that patients with primary aldosteronism are characterised by an elevated A/PRA ratio as compared to individual values of the A/PRA ratios elevated during the study were normal at another preoperative those with essential hypertension and to healthy normotensive controls. Moreover, in the majority of examination in two patients with APA, and in four patients with IHA, while the reverse sequence cases the A/PRA ratio may be indicative of either the tumorous or the non-tumorous form of the disease. occurred in two patients each with APA and IHA. Thus in 10 patients out of 51 the repeat test would Our results are in keeping with those of other workers, [4] [5] [6] [7] [9] [10] [11] [12] although the design of our study difchange the initial classification of patients, albeit the differences in the ratios were usually small. fers from other reports, which may have a bearing on the results. In our material, the A/PRA ratio had and the two primary aldosteronism groups would obviously increase. not been used for screening purposes and had not influenced the diagnostic process, indeed it was calIt had to be expected that the A/PRA correlated positively with plasma A and inversely with PRA. culated from laboratory data retrospectively.
The diagnostic criteria of primary aldosteronism However in our material the correlation with PRA was stronger and the majority of normal A/PRA ratio used in our study may have not conformed to rigid requirements in that in our selection of patients' recconcerned the APA patients with normal PRA. Although the normal PRA in these APA patients is ords we omitted the requisite of an aldosterone suppression test. Therefore, our IHA group may have not consistent with the usual diagnostic criteria of primary aldosteronism, there seems little doubt that included some patients with insufficiently documentd primary aldosteronism. The criteria derived the histologically proven diagnosis in these cases was correct. One has to accept the possibility of norfrom the visualisation procedures cannot be helpful in this regard, since in most instances they were mal PRA in some patients and the probable failure of a single A/PRA ratio determination to screen out based on exclusion of an adrenal tumour and not on the confirmation of a bilateral non-tumorous such cases. It is noteworthy that leading authorities advocate repetitive determinations for screening enlargement of the adrenal glands. Perhaps these reservations may account for some of the normal purposes. 10 We have not taken into account a conceivable histological diversity of the resected aden-A/PRA ratio results in the IHA group, but they do not seem to apply to the APA group. The few elevomas and resulting possible differences in the mechanisms regulating their hormonal activity. The ated A/PRA ratio values found in the EH group may represent low-renin essential hypertension or undiprobability of these factors influencing the A/PRA is a matter of conjecture. The present study confirms agnosed normokalaemic primary aldosteronism although normal plasma aldosterone was present in that the A/PRA ratio may be helpful in screening out patients with normokalaemic APA, since synchronall subjects of this group.
We set the upper limit of normal at 2 standard ously determined serum potassium concentration was normal in over half of the 80 cases for whom deviations above the mean value of the control group, which corresponded to an A/PRA ratio of data were available. However it should be recalled here that hypokalaemia had been present on referral 17.8. With a higher arbitrarily selected cut-off point of 30 or 50, as proposed by other authors, 9,10 nearly in nearly all our patients who were subsequently treated with potassium salts, which increased serum all our patients with EH and all controls would fall into the normal range, but the overlap between them potassium at the time of A/PRA determination. On
